Can Curi Bio’s Curiverse solve the scalability problem in human-relevant drug discovery?
Human-relevant drug screening is hitting a scale problem. Curi Bio’s Curiverse aims to turn 3D tissue models into industrial workflows.
What Viz.ai’s latest hypertrophic cardiomyopathy studies reveal about the future of cardiac AI
Viz.ai’s new HCM studies suggest AI-ECG could improve detection and follow-up. Read what this changes for cardiology workflows and adoption.